| Kimball Lael Christianson, MD | |
|
1055 N 500 W, Suite 112, Bldg. C, Provo, UT 84604 | |
| (801) 812-4624 | |
| (801) 812-4699 |
| Full Name | Kimball Lael Christianson |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 19 Years |
| Location | 1055 N 500 W, Provo, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316113228 | NPI | - | NPPES |
| 1306895016 | Medicaid | ID |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jordan Valley Medical Center | West jordan, UT | Hospital |
| Timpanogos Regional Hospital | Orem, UT | Hospital |
| Mountain View Hospital | Payson, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Utah Clinic Pc | 7517868508 | 391 |
News Archive
Crystallization is a very basic chemical process: School children can witness it with their own eyes. But scientists had not, until now, been able to observe this process on the molecular level - that is, the instant in which molecules overcome their tendencies to float individually in a liquid solution and take their place in the rigid lattice of a solid crystal structure.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
Binge drinking by teenagers and young adults is strongly associated with liking, owning, and correctly identifying music that references alcohol by brand name according to a study by the University of Pittsburgh and Dartmouth-Hitchcock Norris Cotton Cancer Center.
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
› Verified 4 days ago
| Entity Name | Central Utah Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093764805 PECOS PAC ID: 7517868508 Enrollment ID: O20040113000805 |
News Archive
Crystallization is a very basic chemical process: School children can witness it with their own eyes. But scientists had not, until now, been able to observe this process on the molecular level - that is, the instant in which molecules overcome their tendencies to float individually in a liquid solution and take their place in the rigid lattice of a solid crystal structure.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
Binge drinking by teenagers and young adults is strongly associated with liking, owning, and correctly identifying music that references alcohol by brand name according to a study by the University of Pittsburgh and Dartmouth-Hitchcock Norris Cotton Cancer Center.
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimball Lael Christianson, MD 1055 N 500 W, Attn. Credentialing, Provo, UT 84604-4649 Ph: (801) 354-8225 | Kimball Lael Christianson, MD 1055 N 500 W, Suite 112, Bldg. C, Provo, UT 84604 Ph: (801) 812-4624 |
News Archive
Crystallization is a very basic chemical process: School children can witness it with their own eyes. But scientists had not, until now, been able to observe this process on the molecular level - that is, the instant in which molecules overcome their tendencies to float individually in a liquid solution and take their place in the rigid lattice of a solid crystal structure.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
Binge drinking by teenagers and young adults is strongly associated with liking, owning, and correctly identifying music that references alcohol by brand name according to a study by the University of Pittsburgh and Dartmouth-Hitchcock Norris Cotton Cancer Center.
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
› Verified 4 days ago
Dr. Daniel Lyman Corey, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-225-6246 Fax: 801-225-1525 | |
Samuel Lynn Southam, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-7850 Fax: 801-357-7626 | |
Scott D Valadez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Suite 112, Provo, UT 84604 Phone: 801-812-4624 Fax: 801-812-4699 | |
Mark S Asay, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-373-7850 | |
Dr. Derek Scott Bergeson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Attn Credentialing, Provo, UT 84604 Phone: 801-354-8225 Fax: 801-418-0941 | |
Dalton H Wright, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Suite 112, Provo, UT 84604 Phone: 801-812-4624 Fax: 801-812-4699 | |
John S Collins, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-373-7850 |